Anjan Aralihalli

Founder, Raya Therapeutic, Inc., Venture Partner, CTI Life Sciences Fund II, Member Board Of Directors at Muscular Dystrophy Association

Role
Member Board of Directors at Muscular Dystrophy Association
Location
Princeton, NJ, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Anjan Aralihalli

Pharmaceutical/Business Development Executive with 25+ years of international experience. Highly collaborative with exceptional interpersonal and leadership skills. Extensive US/CAN & EU investor and pharma/biotech partner network. Expertise in a large number of therapeutic areas with numerous executed transactions: GI, cardiovascular/thrombosis, dermatology, orthobiologics, regenerative medicine, CNS, diabetes, nutrition, anti-infectives, pain, women\'s health, respiratory and neurodegenerative disease. Specialties: Experience with in & out-licensing, investor relations, corporate development, venture and angel financing, strategic alliances, alliance management, new product development, sales, marketing, & clinical trial management. Speaker at various conferences (including LES and BIO) on topics such as:Psychology of Negotiation, Non-Verbal Communications In Negotiations, The Art & Science of PersuasionProvide consulting services for companies and non-profit organizations associated with ALS.Fluent in English and French.

Experience

  1. Member Board of Directors

    Muscular Dystrophy Association

    Apr 2019 — Present · New York, NY, US

    MDA is committed to transforming the lives of people affected by muscular dystrophy, ALS, and related neuromuscular diseases. We do this through innovations in science and innovations in care. As the largest source of funding for neuromuscular disease research outside of the federal government, MDA has committed more than $1 billion since our inception to accelerate the discovery of therapies and cures. Research we have supported is directly linked to life-changing therapies across multiple neuromuscular diseases. MDA\'s MOVR is the first and only data hub that aggregates clinical, genetic and patient reported data for multiple neuromuscular diseases to improve health outcomes and accelerate drug development. MDA supports the largest network of multidisciplinary clinics providing best in class care at more than 150 of the nation\'s top medical institutions. Our Resource Center serves the community with one-on-one specialized support, and we offer educational conferences, events, and materials for families and healthcare providers. Each year thousands of children and young adults learn vital life skills and gain independence at summer camp and through recreational programs, at no cost to families. For more information visit mda.org.

Education

  • The Johns Hopkins University

    Master of Science (MS), Biotechnology

    2014 — 2018

  • Concordia University

    Bachelor of Science (B.Sc.), Exercise Science

  • Imperial College London

    Mastering Laboratory Skills Short Course

    2018 — 2018

  • Queen's University

    Master of Business Administration (MBA), Finance

Skills

  • Healthcare
  • Business Development
  • Licensing
  • Commercialization
  • Clinical Trials
  • Leadership
  • Strategic Planning
  • Biotechnology
  • Strategy
  • Management
  • Negotiation
  • Pharmaceutical Industry
  • Mergers & Acquisitions
  • Due Diligence
  • Strategic Alliances

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Anjan Aralihalli — Member Board of Directors at Muscular Dystrophy Association in Princeton, NJ, US | Unifers